文献速递甲状腺疾病

激光热消融对生活质量的影响:实性-囊性甲状腺结节患者的改善

The Effect of Laser Thermal Ablation on Quality of Life: Improvements in Patients with Solid-Cystic Thyroid Nodules.
PubMed 文献 · Thyroid · 2022-06-14

这项前瞻性队列研究评估激光热消融(LTA)对良性甲状腺结节患者生活质量的影响,使用甲状腺特异性患者报告结局(ThyPRO)测量。54例患者接受LTA,与丹麦民事登记处739例对照比较;6个月时结节体积中位缩小78%,甲状腺肿症状和生活质量显著改善,79%患者甲状腺肿症状获临床重要改善。

要点

  • LTA后6个月结节体积中位缩小78%(从6.8 mL降至1.8 mL,p < 0.001)。
  • 3个月时甲状腺肿症状改善效应量1.05,美容主诉改善效应量0.50,总体生活质量改善效应量0.64。
  • 6个月时79%患者甲状腺肿症状获大且临床重要的改善,与对照组无临床重要差异。

核心结论

  • 在这项非盲、前瞻性观察性研究中,实性-囊性结节患者疾病特异性生活质量指标较术前显著改善。

研究设计与样本

  • 前瞻性队列研究,使用甲状腺特异性患者报告结局(ThyPRO)测量LTA前、后3个月和6个月的生活质量。
  • 接受LTA的患者(激光组)与来自丹麦民事登记处的特征明确的对照组进行比较。
  • 激光组54例患者,对照组739例,两组年龄和性别无差异。

主要发现

  • 69%患者为复发性囊性甲状腺结节,6%为实性结节,其余25%为混合性质。
  • 结节体积中位数从LTA前6.8 mL(四分位距4.0-11.1)降至LTA后6个月1.8 mL(四分位距0.6-4.1),p < 0.001,对应中位缩小78%。
  • LTA前抽吸全部囊液(中位数6 mL,四分位距2.0-9.0);中位治疗时间400秒(四分位距300-600),应用中位能量823 J(四分位距600-1200)。
  • 基线时激光组较对照组有更多甲状腺肿症状、甲状腺功能亢进症状、疲劳和认知主诉(所有变量p < 0.05),但仅甲状腺肿症状量表差异具临床重要幅度。
  • 3个月时激光组甲状腺肿症状大幅改善(效应量1.05),美容主诉中等改善(效应量0.50),总体生活质量中等改善(效应量0.64);仅甲状腺肿症状和美容主诉量表的改善具临床重要性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文为非盲、前瞻性观察性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Evidence of the efficacy of laser thermal ablation (LTA) in benign thyroid nodules is abundant. However, little is known about the effect on quality of life (QoL) of this treatment. Methods: Prospective cohort study investigating the effect of LTA before, three, and six months after LTA on QoL using the thyroid-specific patient-reported outcome (ThyPRO) measure. Patients receiving LTA (laser group [LG]) was compared with a well-characterized control group (CG) from the Danish civil registry. Results: The LG comprised 54 patients, with no age or sex differences compared with the CG (n = 739). Sixty-nine percent of the patients had a recurrent cystic thyroid nodule, 6% had a solid nodule, while the remaining 25% were of mixed character. The median nodule volume was 6.8 mL (interquartile range [IQR]: 4.0-11.1) before LTA, and 1.8 mL (IQR: 0.6-4.1) at 6 months post-LTA (p < 0.001), corresponding to a median reduction of 78%. All cystic fluid (median: 6 mL; IQR: 2.0-9.0) was aspirated before LTA. Median treatment time was 400 seconds (IQR: 300-600), applying a median energy of 823 J (IQR: 600-1200). At baseline and according to the ThyPRO scales, the LG differed significantly from the CG by having more goiter symptoms, hyperthyroid symptoms, tiredness, and cognitive complaints (p < 0.05 for all variables), but only the difference in the goiter symptom scale was of a clinically important magnitude. At three months, the LG experienced a large improvement in goiter symptoms (effect size [ES] = 1.05), a moderate improvement in cosmetic complaints (ES = 0.50), and a moderate improvement in the overall QoL (ES = 0.64). Only the improvements in the goiter symptom and the cosmetic complaint scales were clinically important. Six months after LTA, the anxiety scale showed further improvement of moderate size (ES = 0.52). At 6 months, the results above were maintained, and 79% of patients experienced a large and clinically important improvement in the goiter symptom scale and no clinically important differences were found between the LG and the CG. Conclusions: In this unblinded, prospective observational study, measures of disease-specific QoL were significantly improved compared with preprocedure levels, in patients with solid-cystic nodules.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Sorensen JR, Døssing H, Watt T, et al. The Effect of Laser Thermal Ablation on Quality of Life: Improvements in Patients with Solid-Cystic Thyroid Nodules. Thyroid. 2022. PMID: 35570722. doi:10.1089/thy.2021.0665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。